Table 4.
Dependent variable | Age (years) range | Mean outcome value, units | Observations (N) used in analyses | Increment (SE) per 1 SD in ln LAP | Increment (SE) per 1 SD in ln BMI |
Total cholesterol | 18–49 | 4.96 mmol/L | 5597 | 0.413 (0.023) | 0.225 (0.018)*** |
50+ | 5.75 mmol/L | 3582 | 0.320 (0.024) | 0.089 (0.022)*** | |
HDL cholesterol | 18–49 | 1.29 mmol/L | 5571 | -0.152 (0.008) | -0.111 (0.007)** |
50+ | 1.32 mmol/L | 3570 | -0.187 (0.009) | -0.109 (0.010)*** | |
LDL cholesterol | 18–49 | 3.09 mmol/L | 3858 | 0.326 (0.023) | 0.220 (0.021)** |
50+ | 3.62 mmol/L | 2754 | 0.146 (0.031) | 0.058 (0.026) | |
Total cholesterol/HDL cholest. | 18–49 | 4.16 mmol/L | 5570 | 0.905 (0.040) | 0.584 (0.033)*** |
50+ | 4.74 mmol/L | 3570 | 0.930 (0.042) | 0.383 (0.042)*** | |
Apolipo-protein B | 18–49 | 0.97 g/L | 2668† | 0.123 (0.006) | 0.074 (0.007)*** |
50+ | 1.16 g/L | 1807† | 0.115 (0.010) | 0.056 (0.007)*** | |
ApoB/ApoA1 | 18–49 | 0.717 | 2642† | 0.115 (0.006) | 0.074 (0.006)*** |
50+ | 0.810 | 1801† | 0.109 (0.009) | 0.069 (0.006)** | |
LDL cholesterol/ApoB | 18–49 | 3.15 mmol/g | 1813† | -0.090 (0.017) | -0.013 (0.012)** |
50+ | 3.19 mmol/g | 1393† | -0.160 (0.018) | -0.066 (0.022)** | |
Uric acid | 18–49 | 315 μmol/L | 5524 | 27 (1) | 25 (1) |
50+ | 334 μmol/L | 3506 | 30 (2) | 23 (2)* | |
Systolic blood pressure | 18–49 | 115.1 mm Hg | 5594 | 3.8 (0.2) | 3.9 (0.2) |
50+ | 134.1 mm Hg | 3580 | 3.1 (0.3) | 2.0 (0.4) | |
Diastolic blood pressure | 18–49 | 72.9 mm Hg | 5592 | 3.7 (0.2) | 3.3 (0.2) |
50+ | 75.5 mm Hg | 3580 | 2.0 (0.2) | 2.0 (0.2) | |
Heart rate | 18–49 | 73.4 bpm | 5482 | 2.4 (0.3) | 1.8 (0.2) |
50+ | 74.1 bpm | 3493 | 2.2 (0.3) | 1.2 (0.3) |
* p < 0.01, ** p < 0.001, *** p < 0.0001, indicating significantly different beta coefficients for ln LAP and ln BMI.
† Lipoprotein data obtained only during phase 1 of NHANES III.